Core Viewpoint - Jiukang Bio (300406.SZ) has recently received a Medical Device Registration Certificate from the Beijing Drug Administration for its product, the Gastrin-17 Assay Kit (Magnetic Microparticle Chemiluminescent Immunoassay), which enhances the company's product portfolio and core competitiveness, positively impacting future development, although it will not have a significant effect on recent production operations and performance [1] Company Summary - The acquisition of the Medical Device Registration Certificate enriches the company's product categories [1] - The new product is expected to strengthen the company's core competitiveness [1] - The impact on recent production and performance is not expected to be significant [1]
九强生物:胃泌素17测定试剂盒取得医疗器械注册证书